Home     About SABCS     Press Releases     Media     Event Photos     Past Symposia     Satellite Symposia     Patient Advocates     FAQs     Contact Us



Registration       Hotel       Presenter Instructions       Support & Exhibits     2014 Overview       Program       Faculty     Travel & Transportation      

Schedule at a Glance
 
Daily Schedule:
Tue. 12/9/2014
Wed. 12/10/2014
Thu. 12/11/2014
Fri. 12/12/2014
Sat. 12/13/2014
 
Poster Sessions:
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Poster Session 5
Poster Session 6
 
Poster Session OT1
Poster Session OT2
Poster Session OT3
 
Poster Discussions:
Poster Discussion 1
Poster Discussion 2
Poster Discussion 3
Poster Discussion 4
Poster Discussion 5
Poster Discussion 6
 

Program Schedule   >  Daily Schedule - Tuesday, December 9, 2014

 
Tuesday | Wednesday | Thursday | Friday | Saturday
TUESDAY, DECEMBER 9, 2014
8:00 am - 7:00 pm REGISTRATION - Bridge Hall  
 

Pre-registered attendees can obtain materials. Those who have not yet registered may do so.

 
     
12:00 pm - 1:30 pm

Career Development Forum: A Networking Session for Young Investigators – Room 214

Networking and career development opportunities for early career scientists. The session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students and residents, who are registered attendees of the SABCS.

Space in the workshop is limited to 220 participants; registrations will be accepted on a first-come, first-served basis and is free of charge.  You can register for this session when you register for the Symposium.

12:00-12:05   Introduction

 

12:05-12:35   Panel Discussion

 

  • John R. Benson, Addenbrooke's Hospital, Cambridge, UNITED KINGDOM
  • Suzanne AW Fuqua, Baylor College of Medicine, Houston, TX
  • Douglas Yee, University of Minnesota Masonic Cancer Center, Minneapolis, MN
  • Additional panelists to be announced

 

12:35-1:30    Roundtables (at press time)

 

Balancing Research and Clinical Practice 1

Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA

 

Balancing Research and Clinical Practice 2

John R. Benson, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UNITED KINGDOM and Mehra Golshan, Brigham and Women's Hospital, Boston, MA

 

Balancing Research and Clinical Practice 3

Lisa A. Carey, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC

 

Careers in Industry 1

Steven Shak, Genomic Health, Inc., Redwood City, CA

 

Careers in Industry 2

Mika Derynck, Genentech, Inc., South San Francisco, CA

 

Careers in Translational Research

Jorge Reis-Filho, MD, PhD, FRCPath, Memorial Sloan-Kettering Cancer Center, New York, NY

 

Grant Writing - Basic/Translational

Ian Kunkler, Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UNITED KINGDOM

 

Grant Writing - Clinical/Translational

Virginia F. Borges, University of Colorado Denver, Aurora, CO and Matthew J. Ellis, Baylor College of Medicine, Houston, TX

 

How to Become a Clinical Trialist
Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA

 

How to Get the Most Out of your Fellowship Years 1

Ingrid A. Mayer, Vanderbilt-Ingram Cancer Center, Nashville, TN

 

How to Get the Most Out of your Fellowship Years 2

Carey K. Anders, University of North Carolina, Chapel Hill, NC

 

How to Get the Most Out of your Predoctoral Experience

Rong Li, UT Health Science Center at San Antonio, San Antonio, TX

 

Making the Transition from Fellowship to Faculty

Michael T. Lewis, Baylor College of Medicine Cancer Center, Houston, TX

 

Mentoring and Supervising

Suzanne AW Fuqua, Baylor College of Medicine, Houston, TX and Douglas Yee, University of Minnesota Masonic Cancer Center, Minneapolis, MN

 

Negotiating a Job Offer or Promotion - Basic Research

Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, AUSTRALIA

 

Negotiating a Job Offer or Promotion - Clinical Research

Sharon H. Giordano, University of Texas MD Anderson Cancer Center, Houston, TX

 

Oral Presentation Skills

Gary C. Chamness, Baylor College of Medicine, Houston, TX

 

Publication Strategies

Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD

 

Searching for a Job and Interviewing - Basic Research

LuZhe Sun, UT Health Science Center at San Antonio, San Antonio, TX

 

Searching for a Job and Interviewing - Clinical Research

Julia White, The James, OSU Comprehensive Cancer Center, Columbus, OH and Melinda Telli, Stanford University, Stanford, CA

 

The Path Leading to Clinical Trials

David Cameron, Edinburgh Cancer Research Centre, Edinburgh, UNITED KINGDOM

 

Career in Grants Administration

Annabell S. Oh, Susan G. Komen, Dallas, TX.

 
     
12:30 pm - 1:30 pm

Special Forum -  Accelerating International Drug Development, Companion Diagnostics, and Their Approval - Hall D

Moderator: Laura J. van 't Veer, PhD

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, CA

Government Perspective

Tatiana M. Prowell, MD
U.S. Food and Drug Administration
Silver Spring, MD

 

Improving access to innovative anticancer medicines: a clinicians viewpoint

Jan H.M. Schellens, MD, PhD

The Netherlands Cancer Institute

Amsterdam, NETHERLANDS

 

Industry perspective on co-development of companion diagnostics with targeted therapies

Eric H. Rubin, MD

Merck & Co.

North Wales, PA

 
     
2:00 pm - 7:00 pm

EDUCATIONAL SESSIONS - Ballrooms A & B and Hall D

Supported in part by an educational grant from Susan G. Komen®

Updates on advances in key areas and in technologies available for translational research. Many of the sessions will provide attendees with a better understanding of the background leading up to talks they will hear in the succeeding days, and some of the techniques that will be used. The presentations should also provide researchers with ideas and techniques to be considered for their own studies.

 
     
2:00 pm - 3:30 pm

Optimizing Clinical Outcomes and Quality of Life in Breast Reconstruction– Ballroom A

Moderator: John Benson, MD

Cambridge University Hospitals NHS Foundation Trust

Cambridge, UNITED KINGDOM

The impact of patient perspective on outcomes in breast reconstruction

Andrea L. Pusic, MD, MHS

Memorial Sloan-Kettering Cancer Center

New York, NY

Reconstruction for the high risk patient: challenges of chemotherapy, radiation therapy and patient selection

Mehra Golshan, MD

Brigham and Women's Hospital

Boston, MA                                   

Delayed and immediate partial breast reconstruction after breast conserving surgery

Krishna B. Clough, MD

L'Institut du Sein - Paris Breast Centre

Paris, FRANCE

HER2 Positive Breast Cancer: Insights from the Lab and Clinic - Ballroom B

Moderator: Mothaffar Rimawi, MD

Baylor College of Medicine

Houston, TX

Mechanisms of HER2 signaling, targeting, and resistance

Mark M. Moasser, MD

University of California

San Francisco, CA

 

Neoadjuvant therapy in HER2 positive breast cancer, latest developments and biomarkers and how it serves as a discovery platform

Sibylle Loibl, MD, PhD

German Breast Group

Neu-Isenburg, GERMANY

Management of metastatic HER2 positive disease: optimizing current therapies and an overview of new agents in development

Ian Krop, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

 

Neoadjuvant Treatment of ER+ Breast Cancer  Hall D

Moderator: Mitchell Dowsett, PhD, FMedSci

Royal Marsden Hospital

London, UNITED KINGDOM

Clinical insights on the neoadjuvant therapy of ER+ breast cancer

David A. Cameron, MD

Edinburgh Cancer Research Centre

Edinburgh, UNITED KINGDOM

Biomarkers for clinical management and research

Mitchell Dowsett, PhD, FMedSci

Royal Marsden Hospital

London, UNITED KINGDOM

 

Integration of novel targeted agents with endocrine therapy

Ingrid A. Mayer, MD, MSCI

Vanderbilt University School of Medicine

Nashville, TN
 
     
3:45 pm - 5:15 pm

New Insights in Breast Radiation – Ballroom A

Moderator: Richard L. Crownover, MD, PhD

UT Health Science Center

San Antonio, TX

Which patients can safely avoid radiation after breast conserving surgery?

Ian H. Kunkler, MB BCHIR, DMRT, FRCR

NHS Lothian Universities Hospitals Trust

Edinburgh, UNITED KINGDOM

 

What have we learned from the randomized trials of partial breast RT?

Ivo A. Olivotto, MD, FRCPC

University of Calgary and Tom Baker Cancer Centre

Calgary, CANADA

 

What is the value of internal mammary chain RT and how can we deliver it safely?

John R. Yarnold, BSC, MB BS, MRCP, FRCR, FRACR

Royal Marsden and Institute of Cancer Research

London, UNITED KINGDOM

Breast Cancer Survivorship: One Size Does Not Fit All – Ballroom B

Moderator: Polly Niravath, MD

Baylor College of Medicine

Houston, TX

Adherence and persistence with adjuvant aromatase inhibitor therapy

Norah Lynn Henry, MD, PhD

University of Michigan

Ann Arbor, MI

 

Second primary cancers among breast cancer survivors:Incidence and risk factors

Christopher I. Li, MD, PhD

Fred Hutchinson Cancer Research Center

Seattle, WA

 

Patient centered treatment summaries and survivorship care plans: enhancing clinical, cultural and linguistic responsiveness

Kimlin Tam Ashing, PhD

City of Hope Medical Center

Duarte, CA

 

Introduction to Immunotherapy  Hall D

Moderator: Douglas Yee, MD

University of Minnesota

Minneapolis, MN

 

Immunotherapeutic approaches to breast cancer

Mary L. (Nora) Disis, MD

University of Washington

Seattle, WA

 

Immune checkpoints and cancer therapy

Jeffrey S. Weber, MD, PhD

Moffitt Cancer Center

Tampa, FL

 

Tumor infiltrating lymphocytes in breast cancer

Sherene Loi, MBBS (Hons), FRACP, PhD

Peter MacCallum Cancer Centre

Melbourne, AUSTRALIA
 
     
5:30 pm - 7:00 pm

Breast Cancer is a Global Disease – Biology, Environment and Health Care Delivery - Ballroom A

Moderator: Melissa Bondy, PhD

Baylor College of Medicine

Houston, TX

 

Global patterns of breast cancer

Benjamin O. Anderson, MD

University of Washington

Seattle, WA

 

Biology vs. Environment – Is biology driving health care disparities

Patricia Thompson, PhD

University of Arizona Cancer Center

Tucson, AZ

 

Breast cancer in developing countries - challenges and opportunities

Hamdy A. Azim, MSc, MD

Cairo University

Cairo, EGYPT

 

Molecular Heterogeneity – Ballroom B

Moderator: Andrea L. Richardson, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

 

Spatial and temporal evolution of breast cancer

Lucy Yates, MBBS, MRCP

The Wellcome Trust Sanger Institute

London, UNITED KINGDOM

 

Circulating plasma tumor DNA as biomarkers for breast cancer therapy

Ben Ho Park, MD, PhD

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, MD

Epigenetic heterogeneity in cancer

Kornelia Polyak, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

 

Triple Negative Breast Cancer - Hall D

Moderator: Nicholas Turner, PhD, FRCP

Royal Marsden and Institute of Cancer Research

London, UNITED KINGDOM

The clinical significance of heterogeneity in triple negative breast cancer

Nicholas Turner, PhD, FRCP

Royal Marsden and Institute of Cancer Research

London, UNITED KINGDOM

 

Targeting the positives in TNBC – platinums, PARPS and novel approaches to high risk disease

Andrew Tutt, PhD

Institute of Cancer Research (ICR)

London, UNITED KINGDOM

 

Adjuvant and neoadjuvant therapy: Current practice and future approaches

Eric P. Winer, MD

Dana-Farber Cancer Institute

Boston, MA
 
 
Wednesday | Thursday | Friday | Saturday
 
 
Home | About SABCS | Press Releases | Media | Event Photos | Past Symposia | Satellite Symposia | Patient Advocates | FAQs | Contact Us
Registration | Hotel | Presenter Instructions | Support & Exhibits | 2014 Overview | Program | Faculty | Travel & Transportation

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550    Fax: 210-450-1560    Email: sabcs@uthscsa.edu
       line
Copyright 2014 SABCS. All rights reserved. - Privacy Policy